It’s Friday, and Unity Biotechnology is Up 97%

(NASDAQ:UBX) shares are soaring this morning on positive earnings and positive results from data in the phase 2 study reported this morning. The stock is $1.67 and has more than 5.7 million in volume and 18,900 trades hours before the open. The VWAP is $1.52 and the previous high volume day in 2021 was around 18 million shares and hit the 52-week high of $3.64 on that day

https://www.globenewswire.com/news-release/2022/08/12/2497481/0/en/UNITY-Biotechnology-Announces-Positive-Data-in-Phase-2-BEHOLD-Study-of-UBX1325-in-Patients-with-Diabetic-Macular-Edema.html

[mstock id=”73007″ asset=”UBX”]

RISK: This post is the author’s view of what’s happening and is not investment advice. Use this information at your own risk as you are responsible for your trading and losses. There is no guarantee any post will be updated and should be taken on an “as is basis” when posted. The market moves and changes quickly which makes the information contained in this post old very quickly.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.